首页|60例小儿急性感染性喉炎治疗效果临床回顾性分析

60例小儿急性感染性喉炎治疗效果临床回顾性分析

扫码查看
目的 分析小儿急性感染性喉炎行布地奈德雾化吸入治疗方案的有效性与可行性。方法 回顾性分析 60 例急性感染性喉炎患儿的临床资料,根据雾化治疗方案的不同分为观察组与对照组,每组 30 例。观察组予布地奈德雾化吸入治疗,对照组予地塞米松雾化吸入治疗。比较两组患儿的临床治疗效果、临床症状持续时间、药物不良反应发生率以及治疗前后的炎症指标。结果 观察组临床治疗总有效率 93。33%(28/30)显著高于对照组的 73。33%(22/30),差异具有统计学意义(P<0。05)。观察组患儿的喉鸣、犬吠样咳嗽、呼吸困难、声音嘶哑、发热持续时间分别为(3。77±1。21)、(3。28±1。06)、(1。78±0。57)、(4。36±0。56)、(1。48±0。48)d,均短于对照组的(4。65±1。26)、(4。77±1。21)、(2。91±0。99)、(5。45±0。49)、(2。56±0。78)d,差异具有统计学意义(P<0。05)。治疗后,两组患儿的超敏C反应蛋白(hs-CRP)水平均较治疗前明显降低,且观察组患儿的hs-CRP水平(7。86±2。13)mg/L低于对照组的(12。67±2。75)mg/L,差异具有统计学意义(P<0。05)。观察组用药不良反应发生率 6。67%低于对照组的 26。67%,差异具有统计学意义(P<0。05)。结论 小儿急性感染性喉炎行布地奈德雾化吸入治疗方案的效果理想,可更为显著地改善患儿的临床症状,缩短临床症状持续时间,同时其安全性较高,具有重要临床应用价值。
Clinical retrospective analysis of 60 cases of acute infectious laryngitis in children
Objective To analyze the effectiveness and feasibility of budesonide aerosol inhalation therapy for children with acute infectious laryngitis.Methods The clinical data of 60 children with acute infectious laryngitis was retrospectively analyzed.According to different aerosol treatment regimen,they were divided into an observation group and a control group,with 30 cases in each group.The observation group was given atomized inhalation of budesonide,and the control group was given atomized inhalation of dexamethasone.The clinical effects,duration of clinical symptoms,incidence of adverse drug reactions and inflammatory indicators before and after treatment were compared between the two groups.Results The total effective rate of the observation group was 93.33%(28/30),which was significantly higher than 73.33%(22/30)of the control group,and the difference was statistically significant(P<0.05).The duration of laryngeal stridor,barking cough,dyspnea,hoarseness and fever of the observation group were(3.77±1.21),(3.28±1.06),(1.78±0.57),(4.36±0.56)and(1.48±0.48)d,which were shorter than(4.65±1.26),(4.77±1.21),(2.91±0.99),(5.45±0.49)and(2.56±0.78)d of the control group,and the difference was statistically significant(P<0.05).After treatment,the hypersensitive C-reactive protein(hs-CRP)level in both groups was significantly lower than that before treatment,and the hs-CRP level of(7.86±2.13)mg/L in the observation group was lower than(12.67±2.75)mg/L in the control group.The difference was statistically significant(P<0.05).The incidence of adverse drug reactions of 6.67%in the observation group was lower than 26.67%in the control group,and the difference was statistically significant(P<0.05).Conclusion Budesonide aerosol inhalation therapy for children with acute infectious laryngitis has an ideal effect,which can significantly improve the clinical symptoms of children and shorten the duration of clinical symptoms.At the same time,it is safe and has important clinical application value.

BudesonideAerosol inhalationDexamethasoneAcute infectious laryngitis in childrenClinical effectAdverse drug reactions

何忠、李生成

展开 >

519000 珠海市妇幼保健院

布地奈德 雾化吸入 地塞米松 小儿急性感染性喉炎 临床疗效 药物不良反应

广东省医学科学技术研究基金

B2018236

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(2)
  • 14